S'abonner

Early life innate immune signatures of persistent food allergy - 06/09/18

Doi : 10.1016/j.jaci.2017.10.024 
Melanie R. Neeland, PhD a, Jennifer J. Koplin, PhD a, Thanh D. Dang, PhD a, b, Shyamali C. Dharmage, MBBS, MSc, MD, PhD a, c, Mimi L. Tang, MBBS, PhD, FRACP, FRCPA, FAAAAI a, b, d, Susan L. Prescott, MD, PhD, FRACP e, Richard Saffery, PhD a, b, David J. Martino, PhD a, b, , Katrina J. Allen, MBBS, BMedSc, FRACP, FAAAI, PhD a, b, d,
a Murdoch Childrens Research Institute, Parkville, Australia 
b Department of Paediatrics, University of Melbourne, Parkville, Australia 
c Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Australia 
d Department of Allergy and Immunology, Royal Children's Hospital, Parkville, Australia 
e Telethon Kids Institute, The University of Western Australia, Perth, Australia 

Corresponding author: Katrina J. Allen, MBBS, BMedSc, FRACP, FAAAI, PhD, Murdoch Children's Research Institute, Department of Allergy and Immunology, The Royal Children's Hospital, Flemington Rd, Parkville, VIC 3052, Australia.Murdoch Children's Research InstituteDepartment of Allergy and ImmunologyThe Royal Children's HospitalFlemington RdParkvilleVIC3052Australia

Abstract

Background

Food allergy naturally resolves in a proportion of food-allergic children without intervention; however the underlying mechanisms governing the persistence or resolution of food allergy in childhood are not understood.

Objectives

This study aimed to define the innate immune profiles associated with egg allergy at age 1 year, determine the phenotypic changes that occur with the development of natural tolerance in childhood, and explore the relationship between early life innate immune function and serum vitamin D.

Methods

This study used longitudinally collected PBMC samples from a population-based cohort of challenge-confirmed egg-allergic infants with either persistent or transient egg allergy outcomes in childhood to phenotype and quantify the functional innate immune response associated with clinical phenotypes of egg allergy.

Results

We show that infants with persistent egg allergy exhibit a unique innate immune signature, characterized by increased numbers of circulating monocytes and dendritic cells that produce more inflammatory cytokines both at baseline and following endotoxin exposure when compared with infants with transient egg allergy. Follow-up analysis revealed that this unique innate immune signature continues into childhood in those with persistent egg allergy and that increased serum vitamin D levels correlate with changes in innate immune profiles observed in children who developed natural tolerance to egg.

Conclusions

Early life innate immune dysfunction may represent a key immunological driver and predictor of persistent food allergy in childhood. Serum vitamin D may play an immune-modulatory role in the development of natural tolerance.

Le texte complet de cet article est disponible en PDF.

Key words : Food allergy, innate, monocytes, persistent, natural tolerance, endotoxin, cytokines, vitamin D, HealthNuts

Abbreviations used : CD, DC, FACS, OFC, SPT


Plan


 The HealthNuts study is supported by funding from the National Health and Medical Research Council of Australia (NHMRC), the Ilhan Food Allergy Foundation, AnaphylaxiStop, the Charles and Sylvia Viertel Medical Research Foundation, and the Victorian Government's Operational Infrastructure Support Program. The immunological work is supported by funding to M.R.N. from the Murdoch Childrens Research Institute and the NHMRC Centre for Food and Allergy Research.
 Disclosure of potential conflict of interest: M. L. Tang receives fees or funding from advisory boards from Nestle and Danone Nutricia; consultancy fees from Deerfield, GLG, and Bayer; grants from the National Health and Medical Research Council (NHMRC) Australia and ProTA Therapeutics; speaker fees from Danone Nutricia and Nestle Health Sciences; royalties from Wilkinson Publishing; and fees for the development of educational presentation from MD Linx; has stock in ProTA Therapeutics; is an inventor on a patent owned by the Murdoch Children's Research Institute; and works with ProTA Therapeutics. S. L. Prescott receives fees or funding from advisory boards from Danone, Nestle, Swisse, and Bayer; consultancy fees from Bayer; and speaker fees from Abbott and Health World and royalties from UpToDate. D. J. Martino received a grant from the NHMRC. The rest of the authors declare that they have no relevant conflicts of interest.


© 2017  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 142 - N° 3

P. 857 - septembre 2018 Retour au numéro
Article précédent Article précédent
  • Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase–induced inflammation
  • Milica Vukmanovic-Stejic, Emma S. Chambers, Mayte Suárez-Fariñas, Daisy Sandhu, Judilyn Fuentes-Duculan, Neil Patel, Elaine Agius, Katie E. Lacy, Carolin T. Turner, Anis Larbi, Veronique Birault, Mahdad Noursadeghi, Neil A. Mabbott, Malcolm H.A. Rustin, James G. Krueger, Arne N. Akbar
| Article suivant Article suivant
  • Accidental food allergy reactions: Products and undeclared ingredients
  • W. Marty Blom, Anouska D. Michelsen-Huisman, Harmieke van Os-Medendorp, Gert van Duijn, Mary-lène de Zeeuw-Brouwer, Astrid Versluis, Jacqueline J.M. Castenmiller, Hubert P.J.M. Noteborn, Astrid G. Kruizinga, André C. Knulst, Geert F. Houben

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.